AURKA and lung carcinoma: We next tested AURKA inhibition in a panel of lung cancer cell lines with different RB1 status and found that the synthetic lethal effect appeared in general in RB1-mutant, SCLC cell lines (Fig. 1k–m; Supplementary Fig. 2g).